NFKB1 and cancer: A number of EGFR signaling pathways have been linked to NFκB activation downstream of ligand stimulation or constitutive EGFR activation in cancer cells, primarily by promoting degradation of inhibitor of kappa B (IkB) proteins that sequester inactive NFκB proteins in the cytoplasm [40,46].